18th week of 2013 patent applcation highlights part 54 |
Patent application number | Title | Published |
20130109655 | Method for mitigating of Prostaglandin E2 reducing side effects of non-steroidal anti-inflammatory drugs | 2013-05-02 |
20130109656 | MITOTIC KINESIN INHIBITORS AND METHODS OF USE THEREOF | 2013-05-02 |
20130109657 | C7-Fluoro Substituted Tetracycline Compounds | 2013-05-02 |
20130109658 | COMPOSITIONS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA | 2013-05-02 |
20130109659 | PHARMACEUTICAL COMPOSITIONS OF CO-CRYSTALS OF TRAMADOL AND COXIBS | 2013-05-02 |
20130109660 | NOVEL PYRIMIDINECARBOXAMIDE DERIVATIVES | 2013-05-02 |
20130109661 | IMIDAZOPYRIDAZINE COMPOUNDS | 2013-05-02 |
20130109662 | Fe(III) Complex Compounds For The Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anemias | 2013-05-02 |
20130109663 | N6-(FERROCENMETHYL)QUINAZOLIN-2,4,6-TRIAMINA (H2) AND THE DERIVATIVES AND PRODRUGS THEREOF AS ANTILEISHMANIAL, ANTIPROTOZOAL, ANTIPARASITIC AND ANTIMICROBIAL AGENTS | 2013-05-02 |
20130109664 | Personal Care Compositions Comprising a Pyrithione and an Iron Chelator | 2013-05-02 |
20130109665 | NOVEL PYRAZINE DERIVATIVES | 2013-05-02 |
20130109666 | METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER | 2013-05-02 |
20130109667 | Chemical Compounds | 2013-05-02 |
20130109668 | AZETIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE | 2013-05-02 |
20130109669 | 6-AMINO-PYRIMIDINE-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS WHICH BIND TO THE SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR FOR THE TREATMENT OF MULTIPLE SCLEROSIS | 2013-05-02 |
20130109670 | TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS | 2013-05-02 |
20130109671 | Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases | 2013-05-02 |
20130109672 | ACTIVATORS OF HUMAN PYRUVATE KINASE | 2013-05-02 |
20130109673 | PROCESSES FOR MAKING ZILPATEROL AND SALTS THEREOF | 2013-05-02 |
20130109674 | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE, AND VASCULAR CONDITIONS | 2013-05-02 |
20130109675 | OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF | 2013-05-02 |
20130109676 | Oxadiazole Diaryl Compounds | 2013-05-02 |
20130109677 | MULTICYCLIC COMPOUNDS AND METHODS OF USE THEREOF | 2013-05-02 |
20130109678 | RADIOPROTECTOR COMPOUNDS AND METHODS | 2013-05-02 |
20130109679 | HETEROCYCLIC COMPOUNDS CONTAINING AN INDOLE CORE | 2013-05-02 |
20130109680 | METHODS AND COMPOSITIONS FOR AMELIORATING THIAZIDE INDUCED HYPERLIPIDEMIA | 2013-05-02 |
20130109681 | ANTI-INFECTIVE AGENTS AGAINST INTRACELLULAR PATHOGENS | 2013-05-02 |
20130109682 | CYCLIC ETHER COMPOUNDS USEFUL AS KINASE INHIBITORS | 2013-05-02 |
20130109683 | 5,6-DIHYDRO-2H-[1,4]OXAZIN-3-YL-AMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) | 2013-05-02 |
20130109684 | GRP94 INHIBITORS | 2013-05-02 |
20130109685 | 1-PHENYL-SUBSTITUTED HETEROCYCLYL DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS | 2013-05-02 |
20130109686 | ISOINDOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | 2013-05-02 |
20130109687 | METHODS OF TREATING HIV INFECTION: INHIBITION OF DNA DEPENDENT PROTEIN KINASE | 2013-05-02 |
20130109688 | Naphthridine derivatives as PI3K inhibitors for the treatment of cancer and immune-inflammatory disease | 2013-05-02 |
20130109689 | Novel Methods for Preparation of (+)-1-ethyl-4-[2-(4-morpholinyl)ethyl)-3,3-diphenyl-2-pyrrolidinone | 2013-05-02 |
20130109690 | NOVEL CRYSTALLINE FORMS OF (3R, 6R)-3-(2,3-DIHYDRO-1H-INDEN-2-YL)-1-[(1R)-1-(2,6-DIMETHYL-3-PYRIDINYL)-2-- (4-MORPHOLINYL)-2-OXOETHYL]-6-[(1S)-1-METHYLPROPYL]-2,5-PIPERAZINEDIONE | 2013-05-02 |
20130109691 | Cosmetic Use of N-Heteroarybisamide Analogs and Related Compounds | 2013-05-02 |
20130109692 | SIGMA LIGANDS FOR THE PREVENTION AND/OR TREATMENT OF EMESIS INDUCED BY CHEMOTHERAPY OR RADIOTHERAPY | 2013-05-02 |
20130109693 | DERIVATIVES OF PYRIDO [3,2-D] PYRIMIDINE, METHODS FOR PREPARATION THEREOF AND THERAPEUTIC USES THEREOF | 2013-05-02 |
20130109694 | COMPOUNDS WITH ANTIBACTERIAL ACTIVITY AGAINST CLOSTRIDIUM | 2013-05-02 |
20130109695 | POLYCYCLIC HETEROARYL SUBSTITUTED TRIAZOLES USEFUL AS AXL INHIBITORS | 2013-05-02 |
20130109696 | Chemical Compounds | 2013-05-02 |
20130109697 | HETEROCYCLIC COMPOUNDS, MEDICAMENTS CONTAINING SAID COMPOUNDS, USE THEREOF AND PROCESSES FOR THE PREPARATION THEREOF | 2013-05-02 |
20130109698 | Small Molecule Inhibitors of Functions of the HIV-1 Matrix Protein | 2013-05-02 |
20130109699 | TETRAHYDROCARBOLINE DERIVATIVE | 2013-05-02 |
20130109700 | Topical Itraconazole Formulations and Uses Thereof | 2013-05-02 |
20130109701 | Chemical Compounds | 2013-05-02 |
20130109702 | TRISUBSTITUTED TRIAZOLOPYRIMIDINES FOR USE IN PLATELET AGGREGATION INHIBITION | 2013-05-02 |
20130109703 | Combination of a GPR119 Agonist and the DPP-IV Inhibitor Linagliptin for Use in the Treatment of Diabetes and Related Conditions | 2013-05-02 |
20130109704 | PURINYL DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | 2013-05-02 |
20130109705 | COMBINATION | 2013-05-02 |
20130109706 | QUINAZOLINE-BASED T CELL PROLIFERATION INHIBITORS | 2013-05-02 |
20130109707 | FLUOROURACIL DERIVATIVES | 2013-05-02 |
20130109708 | Chemical Compounds | 2013-05-02 |
20130109709 | METHODS OF TREATING A BRUTON'S TYROSINE KINASE DISEASE OR DISORDER | 2013-05-02 |
20130109710 | SPIRO COMPOUNDS AND PHARMACEUTICAL USE THEREOF | 2013-05-02 |
20130109711 | NOVEL COMPOUNDS | 2013-05-02 |
20130109713 | ANTIMICROBIAL AGENTS | 2013-05-02 |
20130109714 | NEURODEGENERATIVE DISEASE THERAPEUTIC AGENT | 2013-05-02 |
20130109715 | 6-Substituted isoquinolines and isoquinolinones | 2013-05-02 |
20130109716 | N-AMINOTETRAHYDROISOQUINOLINES AS ANTI-CANCER AGENTS | 2013-05-02 |
20130109717 | SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE- -3-CARBOXAMIDE | 2013-05-02 |
20130109718 | 1-CYCLOALKYL- OR 1-HETEROCYCLYL-HYDROXYIMINO-3-PHENYL-PROPANES | 2013-05-02 |
20130109719 | METHOD OF TREATING ATTENTION DEFICIT DISORDERS WITH D-THREO METHYLPHENIDATE | 2013-05-02 |
20130109720 | INDOLE INHIBITORS OF CRAC | 2013-05-02 |
20130109721 | FAAH Inhibitors | 2013-05-02 |
20130109722 | USE OF DABIGATRAN ETEXILATE FOR TREATING PATIENTS WITH PULMONARY HYPERTENSION | 2013-05-02 |
20130109723 | PESTICIDAL COMPOSITION AND ITS USE | 2013-05-02 |
20130109724 | N-AMINOPYRROLYLMETHYLTETRAHYDROPYRIDINES AS ANTI-CANCER AGENTS | 2013-05-02 |
20130109725 | GRANULES WITH IMPROVED DISPERSION PROPERTIES | 2013-05-02 |
20130109726 | SUSTAINED-RELEASE THERAPEUTIC AGENT FOR HYPERTENSION AND RENAL DYSFUNCTION | 2013-05-02 |
20130109727 | BIOCIDE | 2013-05-02 |
20130109728 | BIOCIDE COMPOSITION | 2013-05-02 |
20130109729 | PHARMACEUTICAL COMPOSITION | 2013-05-02 |
20130109730 | TREATMENT OF LIVER DISEASES IN WHICH IRON PLAYS A ROLE IN PATHOGENESIS | 2013-05-02 |
20130109731 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR MAKING SAME | 2013-05-02 |
20130109732 | PESTICIDAL COMPOSITION AND ITS USE | 2013-05-02 |
20130109733 | Combination of Selected Analgesics and Cox-II Inhibitors | 2013-05-02 |
20130109734 | GPR120 RECEPTOR AGONISTS AND USES THEREOF | 2013-05-02 |
20130109735 | SALACINOL AND PONKORANOL HOMOLOGUES, DERIVATIVES THEREOF, AND METHODS OF SYNTHESIZING SAME | 2013-05-02 |
20130109736 | METHOD FOR ENHANCED UPTAKE OF VIRAL VECTORS IN THE MYOCARDIUM | 2013-05-02 |
20130109737 | MEDIATOR AND COHESIN CONNECT GENE EXPRESSION AND CHROMATIN ARCHITECTURE | 2013-05-02 |
20130109738 | Control of Cardiac Growth, Differentiation and Hypertrophy | 2013-05-02 |
20130109739 | COMPOSITIONS AND METHODS FOR SHORT INTERFERING NUCLEIC ACID INHIBITION OF NAV1.8 | 2013-05-02 |
20130109740 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF BETA-CATENIN BY DOUBLE-STRANDED RNA | 2013-05-02 |
20130109741 | MiRNA AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH MELANOMA, OR IN DISEASES OR CONDITIONS ASSOCIATED WITH ACTIVATED BRAF PATHWAY | 2013-05-02 |
20130109742 | Restrictive Inverted Terminal Repeats for Viral Vectors | 2013-05-02 |
20130109743 | NUCLEIC ACID DELIVERY COMPOSITION AND CARRIER COMPOSITION, PHARMACEUTICAL COMPOSITION USING THE SAME, AND METHOD FOR DELIVERING NUCLEIC ACID | 2013-05-02 |
20130109744 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIABETES | 2013-05-02 |
20130109745 | ANTI-ANGIOGENIC COMPOSITION CONTAINING MACROLACTIN A AND A DERIVATIVE THEREOF AS ACTIVE INGREDIENTS | 2013-05-02 |
20130109746 | COMPOSITION COMPRISING ELLAGIC ACID AND A PARTICULAR CATIONIC SURFACTANT, AND COSMETIC USE THEREOF | 2013-05-02 |
20130109747 | PHARMACEUTICAL FORMULATION | 2013-05-02 |
20130109748 | METHOD FOR OBTAINING EXTRACT OF CALLIGONUM SPECIES AND EXTRACT THEREOF | 2013-05-02 |
20130109749 | MICHELIOLIDE DERIVATIVES, MEDICINAL COMPOSITION, PRODUCING METHOD AND USAGE THEREOF | 2013-05-02 |
20130109750 | NOVEL ARYLAMIDE DERIVATIVES HAVING ANTIANDROGENIC PROPERTIES | 2013-05-02 |
20130109751 | LSD-1 ENZYME INHIBITORS FOR INDUCING OSTEOGENIC DIFFERENTIATION | 2013-05-02 |
20130109752 | DERIVATIVE OF 18beta-GLYCYRRHETINIC ACID APT TO SUPPRESS CANCER CELLS | 2013-05-02 |
20130109753 | SN-2-MONOACYLGLYCEROLS AND LIPID MALABSORPTION | 2013-05-02 |
20130109754 | COMBINATION OF AN NSAID AND AN AMINO ACID | 2013-05-02 |
20130109755 | Baclofen Formulations and Methods for Making Same | 2013-05-02 |